DexCom Stock Plunge: Hunterbrook Report Triggers Investor Fears
DexCom's nightmare: A bombshell report from Hunterbrook Capital sent DexCom shares plummeting! Accusations of G7 device failures, questionable accounting, and a CEO exit have investors running scared. Is this a buying opportunity or the beginning of the end for the glucose monitoring giant? Find out what's behind the chaos and what's next for DexCom. Hosted on Acast. See acast.com/privacy for more information.